AMRX
Amneal Pharmaceuticals, Inc.Company with tickers: AMRX
Market Cap
$5.51B
Shares Outstanding
319,022,792
CIK
1723128
CUSIP
03168L105
13F Activity (30d)
3 filings
2 filers
Website
Visit website
Investor Relations
Investor relations
Share-repurchase activity from the company's own XBRL filings — cash spent on equity repurchases (common and preferred combined, as reported) per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2016-12-31 | $5,000 | 10-K, filed 2019-03-01 |